
Robert S. Cabral
Examiner (ID: 18249, Phone: (571)270-3769 , Office: P/1618 )
| Most Active Art Unit | 1618 |
| Art Unit(s) | 1618, 1614 |
| Total Applications | 949 |
| Issued Applications | 549 |
| Pending Applications | 83 |
| Abandoned Applications | 341 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16612221
[patent_doc_number] => 20210030874
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => Method of enhancing the antimicrobial action of systemically administered antibiotics
[patent_app_type] => utility
[patent_app_number] => 16/983171
[patent_app_country] => US
[patent_app_date] => 2020-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6404
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16983171
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/983171 | Method of enhancing the antimicrobial action of systemically administered antibiotics | Aug 2, 2020 | Issued |
Array
(
[id] => 16627539
[patent_doc_number] => 20210046192
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-18
[patent_title] => STABLE COMPOSITIONS OF MRNA-LOADED LIPID NANOPARTICLES AND PROCESSES OF MAKING
[patent_app_type] => utility
[patent_app_number] => 16/936909
[patent_app_country] => US
[patent_app_date] => 2020-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21155
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16936909
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/936909 | Stable compositions of MRNA-loaded lipid nanoparticles and processes of making | Jul 22, 2020 | Issued |
Array
(
[id] => 16539212
[patent_doc_number] => 20200405625
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => SOLID DRUG TABLETS FOR IMPLANTABLE DRUG DELIVERY DEVICES
[patent_app_type] => utility
[patent_app_number] => 16/932229
[patent_app_country] => US
[patent_app_date] => 2020-07-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27071
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16932229
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/932229 | Solid drug tablets for implantable drug delivery devices | Jul 16, 2020 | Issued |
Array
(
[id] => 18075973
[patent_doc_number] => 20220401585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => A UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR-TARGETING PEPTIDE
[patent_app_type] => utility
[patent_app_number] => 17/625973
[patent_app_country] => US
[patent_app_date] => 2020-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9593
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17625973
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/625973 | A UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR-TARGETING PEPTIDE | Jul 14, 2020 | Pending |
Array
(
[id] => 18075973
[patent_doc_number] => 20220401585
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => A UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR-TARGETING PEPTIDE
[patent_app_type] => utility
[patent_app_number] => 17/625973
[patent_app_country] => US
[patent_app_date] => 2020-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9593
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17625973
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/625973 | A UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR-TARGETING PEPTIDE | Jul 14, 2020 | Pending |
Array
(
[id] => 16397341
[patent_doc_number] => 20200338199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => SODIUM CHLORIDE SOLUTION FOR DRUG RECONSTITUTION OR DILUTION
[patent_app_type] => utility
[patent_app_number] => 16/946998
[patent_app_country] => US
[patent_app_date] => 2020-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11962
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16946998
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/946998 | SODIUM CHLORIDE SOLUTION FOR DRUG RECONSTITUTION OR DILUTION | Jul 13, 2020 | Abandoned |
Array
(
[id] => 16984601
[patent_doc_number] => 11071751
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-27
[patent_title] => Hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agent
[patent_app_type] => utility
[patent_app_number] => 16/927777
[patent_app_country] => US
[patent_app_date] => 2020-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 11282
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16927777
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/927777 | Hypertonic pharmaceutical compositions containing an anti-platinum chemoprotectant agent | Jul 12, 2020 | Issued |
Array
(
[id] => 17421259
[patent_doc_number] => 11254701
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-22
[patent_title] => Spinosyn formulations for treatment of
[patent_app_type] => utility
[patent_app_number] => 16/913567
[patent_app_country] => US
[patent_app_date] => 2020-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 17816
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16913567
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/913567 | Spinosyn formulations for treatment of | Jun 25, 2020 | Issued |
Array
(
[id] => 19091009
[patent_doc_number] => 11952439
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-09
[patent_title] => Surface gradient cross-linking method of ultra-high molecular weight polyethylene and the application thereof
[patent_app_type] => utility
[patent_app_number] => 16/911831
[patent_app_country] => US
[patent_app_date] => 2020-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 11153
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16911831
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/911831 | Surface gradient cross-linking method of ultra-high molecular weight polyethylene and the application thereof | Jun 24, 2020 | Issued |
Array
(
[id] => 20270816
[patent_doc_number] => 12440582
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-14
[patent_title] => Biothiol-activatable probe and method of use
[patent_app_type] => utility
[patent_app_number] => 17/620312
[patent_app_country] => US
[patent_app_date] => 2020-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 60
[patent_no_of_words] => 18456
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17620312
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/620312 | Biothiol-activatable probe and method of use | Jun 16, 2020 | Issued |
Array
(
[id] => 16359505
[patent_doc_number] => 20200316256
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => REINFORCED TISSUE GRAFT
[patent_app_type] => utility
[patent_app_number] => 16/903920
[patent_app_country] => US
[patent_app_date] => 2020-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7403
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16903920
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/903920 | Reinforced tissue graft | Jun 16, 2020 | Issued |
Array
(
[id] => 20270816
[patent_doc_number] => 12440582
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-14
[patent_title] => Biothiol-activatable probe and method of use
[patent_app_type] => utility
[patent_app_number] => 17/620312
[patent_app_country] => US
[patent_app_date] => 2020-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 60
[patent_no_of_words] => 18456
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17620312
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/620312 | Biothiol-activatable probe and method of use | Jun 16, 2020 | Issued |
Array
(
[id] => 17525713
[patent_doc_number] => 11298379
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-12
[patent_title] => Compositions comprising milk fat globules and methods of making same
[patent_app_type] => utility
[patent_app_number] => 16/898804
[patent_app_country] => US
[patent_app_date] => 2020-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9642
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16898804
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/898804 | Compositions comprising milk fat globules and methods of making same | Jun 10, 2020 | Issued |
Array
(
[id] => 17760115
[patent_doc_number] => 20220233727
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => SURFACE ENHANCED RAMAN SCATTERING NANOPARTICLES AND THEIR USE IN DETECTING AND IMAGING OXIDATIVE STRESS
[patent_app_type] => utility
[patent_app_number] => 17/617462
[patent_app_country] => US
[patent_app_date] => 2020-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19286
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17617462
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/617462 | SURFACE ENHANCED RAMAN SCATTERING NANOPARTICLES AND THEIR USE IN DETECTING AND IMAGING OXIDATIVE STRESS | Jun 9, 2020 | Pending |
Array
(
[id] => 16326667
[patent_doc_number] => 20200297632
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-24
[patent_title] => DELIVERY OF AGENTS TO INFLAMED TISSUES USING FOLATE-TARGETED LIPOSOMES
[patent_app_type] => utility
[patent_app_number] => 16/894287
[patent_app_country] => US
[patent_app_date] => 2020-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12625
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16894287
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/894287 | Delivery of agents to inflamed tissues using folate-targeted liposomes | Jun 4, 2020 | Issued |
Array
(
[id] => 19650084
[patent_doc_number] => 12171844
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-12-24
[patent_title] => Method of preparing a radioactive yttrium phosphate particle suspension
[patent_app_type] => utility
[patent_app_number] => 17/638559
[patent_app_country] => US
[patent_app_date] => 2020-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 2170
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 273
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17638559
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/638559 | Method of preparing a radioactive yttrium phosphate particle suspension | Jun 1, 2020 | Issued |
Array
(
[id] => 17733162
[patent_doc_number] => 20220218621
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-14
[patent_title] => EXTRACELLULAR VESICLES FOR DELIVERING THERAPEUTIC OR DIAGNOSTIC DRUGS
[patent_app_type] => utility
[patent_app_number] => 17/615302
[patent_app_country] => US
[patent_app_date] => 2020-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5289
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17615302
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/615302 | EXTRACELLULAR VESICLES FOR DELIVERING THERAPEUTIC OR DIAGNOSTIC DRUGS | May 28, 2020 | Pending |
Array
(
[id] => 16909023
[patent_doc_number] => 11041050
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-22
[patent_title] => Cationic mucic acid polymer-based delivery systems
[patent_app_type] => utility
[patent_app_number] => 16/880065
[patent_app_country] => US
[patent_app_date] => 2020-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 40
[patent_no_of_words] => 19157
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16880065
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/880065 | Cationic mucic acid polymer-based delivery systems | May 20, 2020 | Issued |
Array
(
[id] => 16620118
[patent_doc_number] => 20210038771
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => SCAFFOLDS FOR CELL COLLECTION OR ELIMINATION
[patent_app_type] => utility
[patent_app_number] => 16/877805
[patent_app_country] => US
[patent_app_date] => 2020-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12123
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16877805
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/877805 | SCAFFOLDS FOR CELL COLLECTION OR ELIMINATION | May 18, 2020 | Abandoned |
Array
(
[id] => 17720445
[patent_doc_number] => 20220213165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-07
[patent_title] => THERAPEUTIC PEPTIDES
[patent_app_type] => utility
[patent_app_number] => 17/609536
[patent_app_country] => US
[patent_app_date] => 2020-05-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20316
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -52
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17609536
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/609536 | Therapeutic peptides | May 7, 2020 | Issued |